Microfluidic Card Pcr
Microfluidic Card Pcr - Related Videos
01:28
Credit Card Sales
0 Views •
2025
Credit card transactions have become a dominant payment method in many retail environments, offering businesses more than just customer convenience. One key operational advantage is the mitigation of credit risk since payment collection shifts to the credit card issuer rather than the merchant. This arrangement streamlines cash inflows and reduces exposure to defaults and delayed payments.Transaction Costs and Cash Flow ImpactWhen a business accepts credit card payments, it typically pays a...
07:19
Executive Function and the Dimensional Change Card Sort Task
0 Views •
2023
Source: Laboratories of Nicholaus Noles and Judith Danovitch—University of Louisville Infants are born with amazing cognitive resources at their disposal, but they don’t know how to use them effectively. In order to harness the power of their brains, humans must develop high-level cognitive processes that manage basic brain functions. These processes make up what psychologists refer to as executive function. Executive function is a key factor in many self-regulatory behaviors, including forming...
10:21
Microfluidic Applications for Disposable Diagnostics
0 Views •
Cited by 1 •
2008
In this interview, Dr. Klapperich discusses the fabrication of thermoplastic microfluidic devices and their application for development of new diagnostics.
12:09
Avian Influenza Surveillance with FTA Cards: Field Methods, Biosafety, and Transportation Issues Solved
0 Views •
Cited by 42 •
2011
A method to preserve, detect and sequence RNA from Avian Influenza Viruses was validated and extended using natural faecal samples from birds. This technique removes the necessity of maintaining a cool chain and handling of infectious viruses and can be applied in a 96-well high-throughput setup.
10:28
Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
0 Views •
Cited by 33 •
2015
Circulating microRNAs have recently emerged as promising and novel biomarkers for various cancers and other diseases. The goal of this article is to discuss three different probe-based real-time PCR platforms and methods that are available to quantify and determine the abundance of circulating microRNAs.
FAQs
Each reaction chamber undergoes repeated temperature cycles that separate the DNA strands, allow primers to direct extension, and produce additional copies of the selected sequence. Because the chambers operate within the card’s array, many target-specific reactions can proceed in parallel. This coordinated cycling enables fluorescence-based detection after amplification while using only small reaction volumes.
Miniaturization places reactions in small chambers and reduces the amount of reagent required for each test. The array format also allows numerous reactions to run at the same time, which can shorten overall processing compared with handling reactions individually. These features make the approach useful when researchers need efficient analysis from limited cancer research samples.
Multiplex analysis allows the card to examine multiple genes, mutations, or biomarkers within a single organized testing format. Different reactions can be directed toward different selected sequences, while fluorescence provides a way to identify amplified targets. This broader molecular readout helps researchers assess several cancer-related changes rather than focusing on one sequence at a time.
A typical workflow begins by preparing the sample and PCR mixtures, then distributing those materials into the card’s array of reaction chambers. The loaded card undergoes repeated temperature cycling to amplify selected DNA sequences. Finally, fluorescence-based detection indicates which targets were amplified, producing a molecular profile for subsequent cancer research analysis.
Researchers may choose this approach when they need parallel analysis of genes, mutations, or biomarkers from a limited clinical sample. Its compact, high-throughput format supports efficient screening and can generate molecular information relevant to tumor classification. The same type of information may also contribute to studying treatment selection and monitoring disease-related changes.
The method provides fluorescence-based evidence of selected DNA sequences after amplification, allowing researchers to assess the molecular features represented in the tested sample. In cancer studies, those results can help characterize genetic or biomarker changes associated with tumors. Such profiles support investigations of classification, treatment-related decisions, and disease monitoring, depending on the targets included.